Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases
BackgroundPancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has yet to be explored. We aimed to explore prognostic-related immune genes and develop a prediction model for indicating prognosis...
Main Authors: | Miaobin Mao, Hongjian Ling, Yuping Lin, Yanling Chen, Benhua Xu, Rong Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.702102/full |
Similar Items
-
GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
by: Bo Liu, et al.
Published: (2021-05-01) -
Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
by: Dongjie Chen, et al.
Published: (2021-10-01) -
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
by: Rong Tang, et al.
Published: (2021-03-01) -
Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma
by: Ligong Yuan, et al.
Published: (2021-08-01) -
Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes
by: Willem de Koning, et al.
Published: (2021-04-01)